Clinical Edge Journal Scan

Gastric ulcer increases the risk for gastric cancer


 

Key clinical point: Gastric ulcer (GU) is positively associated with the risk for gastric cancer, whereas duodenal ulcer (DU) shows no association with gastric cancer risk.

Major finding: GU was associated with an increased risk for gastric cancer (odds ratio [OR] 3.04; 95% CI 2.07-4.49). No association between DU and gastric cancer risk was observed (OR 1.03; 95% CI 0.77-1.39).

Study details: This pooled analysis of 11 case-control studies in the Stomach Cancer Pooling Consortium investigated the association between peptic ulcer disease and gastric cancer among 4106 patients with gastric cancer and 6922 control individuals.

Disclosures: This study was sponsored by Associazione Italiana per la Ricerca sul Cancro, Italy, and others. The authors declared no conflicts of interest.

Source: Paragomi P et al. The association between peptic ulcer disease and gastric cancer: Results from the Stomach Cancer Pooling (StoP) project consortium. Cancers (Basel). 2022;14(19):4905 (Oct 7). Doi: 10.3390/cancers14194905

Recommended Reading

Effect of early treatment and oxaliplatin discontinuation in patients with stage III colon cancer
MDedge Hematology and Oncology
Metastatic microsatellite-stable CRC: CXD101 and nivolumab combo shows promise in phase 2
MDedge Hematology and Oncology
Impact of synchronous ovarian metastases on 3-year overall survival in CRC
MDedge Hematology and Oncology
High risk for incident cardiovascular disease in patients with high-risk stage II-III CRC
MDedge Hematology and Oncology
CRC: Severe inflammatory response in early postoperative period increases risk for recurrence
MDedge Hematology and Oncology
Excellent prognostic ability of neutrophil-to-lymphocyte ratio in CRC liver metastasis
MDedge Hematology and Oncology
mCRC: Triplet+bevacizumab offers survival advantage even in patients with bone metastasis
MDedge Hematology and Oncology
Comparative analysis of total neoadjuvant therapy vs standard therapy in LARC
MDedge Hematology and Oncology
ctDNA detection following curative surgery for colorectal cancer predicts poor prognosis
MDedge Hematology and Oncology
Bemarituzumab shows promising efficacy in patients with FGFR2b-selected gastric cancer
MDedge Hematology and Oncology